East SJ - Search Results

1

Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes.

East SJ, Hill MP, Brotchie JM. East SJ, et al. Eur J Pharmacol. 1995 Apr 13;277(1):117-21. doi: 10.1016/0014-2999(95)00119-6. Eur J Pharmacol. 1995. PMID: 7635167

2

Ionotropic glutamate receptors and nitric oxide synthesis in the rat striatum.

East SJ, Parry-Jones A, Brotchie JM. East SJ, et al. Neuroreport. 1996 Dec 20;8(1):71-5. doi: 10.1097/00001756-199612200-00015. Neuroreport. 1996. PMID: 9051755

3

Actions of a metabotropic glutamate receptor agonist in immature and adult rat cerebellum.

East SJ, Garthwaite J. East SJ, et al. Eur J Pharmacol. 1992 Sep 4;219(3):395-400. doi: 10.1016/0014-2999(92)90480-r. Eur J Pharmacol. 1992. PMID: 1385175

4

Nanomolar N(G)-nitroarginine inhibits NMDA-induced cyclic GMP formation in rat cerebellum.

East SJ, Garthwaite J. East SJ, et al. Eur J Pharmacol. 1990 Aug 10;184(2-3):311-3. doi: 10.1016/0014-2999(90)90623-e. Eur J Pharmacol. 1990. PMID: 1964129

5

Selective blockade of N-methyl-D-aspartate receptor function by the nitric oxide donor, nitroprusside.

East SJ, Batchelor AM, Garthwaite J. East SJ, et al. Eur J Pharmacol. 1991 Dec 10;209(1-2):119-21. doi: 10.1016/0014-2999(91)90021-h. Eur J Pharmacol. 1991. PMID: 1687680

6

NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the L-arginine-nitric oxide pathway.

East SJ, Garthwaite J. East SJ, et al. Neurosci Lett. 1991 Feb 11;123(1):17-9. doi: 10.1016/0304-3940(91)90147-l. Neurosci Lett. 1991. PMID: 1648186

7

Excitatory amino acid receptors coupled to the nitric oxide/cyclic GMP pathway in rat cerebellum during development.

Southam E, East SJ, Garthwaite J. Southam E, et al. Among authors: east sj. J Neurochem. 1991 Jun;56(6):2072-81. doi: 10.1111/j.1471-4159.1991.tb03468.x. J Neurochem. 1991. PMID: 1673999

8

DNA interstrand cross-linking and TP53 status as determinants of tumour cell sensitivity in vitro to the antibody-directed enzyme prodrug therapy ZD2767.

Monks NR, Blakey DC, East SJ, Dowell RI, Calvete JA, Curtin NJ, Arris CE, Newell DR. Monks NR, et al. Among authors: east sj. Eur J Cancer. 2002 Jul;38(11):1543-52. doi: 10.1016/s0959-8049(02)00111-9. Eur J Cancer. 2002. PMID: 12110502

9

ZD2767, an improved system for antibody-directed enzyme prodrug therapy that results in tumor regressions in colorectal tumor xenografts.

Blakey DC, Burke PJ, Davies DH, Dowell RI, East SJ, Eckersley KP, Fitton JE, McDaid J, Melton RG, Niculescu-Duvaz IA, Pinder PE, Sharma SK, Wright AF, Springer CJ. Blakey DC, et al. Among authors: east sj. Cancer Res. 1996 Jul 15;56(14):3287-92. Cancer Res. 1996. PMID: 8764123

10

Cellular glutathione as a determinant of the sensitivity of colorectal tumour cell-lines to ZD2767 antibody-directed enzyme prodrug therapy (ADEPT).

Monks NR, Calvete JA, Curtin NJ, Blakey DC, East SJ, Newell DR. Monks NR, et al. Among authors: east sj. Br J Cancer. 2000 Jul;83(2):267-9. doi: 10.1054/bjoc.2000.1240. Br J Cancer. 2000. PMID: 10901381 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20 results

Search Page

Filters